Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universitaire Ziekenhuizen KU Leuven
With
KU Leuven
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
For lactating mothers
Lactating
0-6 months postpartum
Age: ≥18 year
On steady state ACE-inhibitor therapy, for any indication (e.g. perindopril, captopril, cilazapril, enalapril, fosinopril, lisinopril, quinapril, ramipril \& zofenopril)
Willing to express breast milk
Informed consent to participate and for processing their personal data
For neonates/infants
0-6 months of age at inclusion of the mother
Postmenstrual age: ≥ 37 weeks
In case of blood sampling: exclusively breastfed at the time of sampling
Parental informed consent to participate and for processing their personal data
You may not be if
Participation in a trial with an investigational product within the previous three months
Clareo Health | Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast Milk
